EANS-Adhoc: BWT Aktiengesellschaft
BWT Extraordinary General Meeting
unanimously approves takeover of the Pharma business of CHRIST
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement.
Company Information
10.08.2009
Today´s Extraordinary General Meeting of BWT unanimously gave approval to the takeover of the Pharma business of Christ Water Technology AG. With the deal, BWT is taking a leading position in the sophisticated international market for pharma-water systems with innovative high-end solutions under the brand "Christ Aqua" true to the motto "Safety, hygiene and health in contact with the elixir of water".
Votes present: 10,461,995 Votes "Yes": 10,397,675 Votes "No": 0 Abstentions: 64,320 The resolution was passed with: 100.00%
The Agenda and further details of the General Meeting can be found on the website of BWT AG in section Investor Relations.
end of announcement euro adhoc
Further inquiry note:
BWT Aktiengesellschaft
Mag. Ralf Burchert
ralf.burchert@bwt.at
Tel.: 06232/5011-1113
Branche: Water Supply
ISIN: AT0000737705
WKN: 884042
Index: ATX Prime
Börsen: Wien / official market